During the past decade, Weifang People's Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Weifang People's Hospital" are "Esophageal Cancer" (1 trials) and "Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Weifang People's Hospital" in a lesser frequency.

Most popular intervention types in "Weifang People's Hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (1 trials), "Atezolizumab Matching Placebo" (1 trials), "Cisplatin" (1 trials), "Giredestrant" (1 trials) and "Giredestrant-matched Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Weifang People's Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Weifang People's Hospital". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Weifang People's Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Weifang People's Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".